however, no statistically significant differences were observed among the control, semaglutide, and tirzepatide groups in the early DM and late DM groups (Fig
GLP-1 also helps control and lower blood sugar and decrease how much food you eat and is prescribed for adults with type-2 diabetes
Conclusion GLP-1RA reduced the risk of MI, stroke, cardiovascular mortality and MACE in a broad range of patients with and without T2DM and/or prior ASCVD, supporting its role in ASCVD prevention, especially in the cohort with high BMI
Anyone experiencing memory problems or cognitive changes should consult their GP for appropriate investigation, which may include cognitive screening, blood tests, and neuroimaging as per NICE guidance (NG97)
Generative molecular design in low data regimes
Semaglutide: Review and Place in Therapy for Adults With Type 2 Diabetes